Aims

This study will make use of innovative brain scanning techniques to examine the relationship between the levels of hallmark Alzheimer’s proteins amyloid and tau, and the activity of the brain’s immune system. The team will study people with early memory and thinking problems called mild cognitive impairment (MCI), as well as people with Alzheimer’s disease and healthy controls. By comparing the brain scans of people in these different groups, the researchers hope to discover more about how Alzheimer’s progresses, and develop a timeline of the changes that take place in the brains of people with the disease.